Duopharma Biotech Berhad (KLSE:DPHARMA)

Malaysia · Delayed Price · Currency is MYR

1.260

-0.030 (-2.33%)

At close: Nov 18, 2025

Revenue by Product

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2003 - 2019
Pharmaceutical Products	813.70M	Log In	Log In	Log In	Log In	Upgrade
Pharmaceutical Products Growth	15.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2003 - 2019
Malaysia	754.18M	Log In	Log In	Log In	Log In	Upgrade
Malaysia Growth	15.93%	Log In	Log In	Log In	Log In	Upgrade
International	59.51M	Log In	Log In	Log In	Log In	Upgrade
International Growth	9.84%	Log In	Log In	Log In	Log In	Upgrade